The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling

Tumor microenvironment (TME) plays a core role in the genesis and progress of endometrial carcinoma (EC). The immune system, a crucial element of TME, functions in various immune cells. In this paper, we have tried to evaluate the prognosis in EC patients by the status of TME. The ESTIMATE algorithm...

Full description

Bibliographic Details
Main Authors: Lin Xu, Qin Fang, Youqing Miao, Mengting Xu, Yichun Wang, Lizhou Sun, Xuemei Jia
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Bioengineered
Subjects:
Online Access:http://dx.doi.org/10.1080/21655979.2021.1947631
_version_ 1798033979448754176
author Lin Xu
Qin Fang
Youqing Miao
Mengting Xu
Yichun Wang
Lizhou Sun
Xuemei Jia
author_facet Lin Xu
Qin Fang
Youqing Miao
Mengting Xu
Yichun Wang
Lizhou Sun
Xuemei Jia
author_sort Lin Xu
collection DOAJ
description Tumor microenvironment (TME) plays a core role in the genesis and progress of endometrial carcinoma (EC). The immune system, a crucial element of TME, functions in various immune cells. In this paper, we have tried to evaluate the prognosis in EC patients by the status of TME. The ESTIMATE algorithm was implemented to computer the number of immune and stromal components in EC tissues from the Cancer Genome Atlas dataset. The CIBERSORT algorithm was employed to assess the proportion of tumor-infiltrating immune cells in EC tissues, which were quantified as Stromal score and Immune score. After the construction of protein–protein interaction network, cell–cell chemokine receptor 2 (CCR2) was identified as a potential predictive element for EC. Further analysis indicated that a higher expression of CCR2 in EC patients was correlated with a better prognosis and a prolonged disease-free survival. According to the transcript level of CCR2, samples were separated into low- and high-expression groups. Gene Set Enrichment Analysis unveiled that metabolism-related pathways were mostly abundant in groups with high-expression, the other one was primarily correlated to immune-related activities. We figured out that some immune cells were positively related to CCR2, suggesting that CCR2 might serve as the immune-dominant status of TME, which was verified by qRT-PCR and HPA analysis in transcriptome and protein level, respectively. Also, CCR2 showed high correlation with immune modulators and chemokine signaling pathway. Thus, the level of CCR2 might have a prognostic value for EC patients, which provides a novel insight for therapeutic strategies of EC.
first_indexed 2024-04-11T20:37:53Z
format Article
id doaj.art-7c19851cd52f447784ee170a6b2d91ad
institution Directory Open Access Journal
issn 2165-5979
2165-5987
language English
last_indexed 2024-04-11T20:37:53Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Bioengineered
spelling doaj.art-7c19851cd52f447784ee170a6b2d91ad2022-12-22T04:04:18ZengTaylor & Francis GroupBioengineered2165-59792165-59872021-01-011213467348410.1080/21655979.2021.19476311947631The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodelingLin Xu0Qin Fang1Youqing Miao2Mengting Xu3Yichun Wang4Lizhou Sun5Xuemei Jia6The Affiliated Obstetrics and Gynecology Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care HospitalThe Affiliated Obstetrics and Gynecology Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care HospitalNanjing Drum Tower HospitalThe First Affiliated Hospital of Nanjing Medical UniversityThe First Affiliated Hospital of Nanjing Medical UniversityThe First Affiliated Hospital of Nanjing Medical UniversityThe Affiliated Obstetrics and Gynecology Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care HospitalTumor microenvironment (TME) plays a core role in the genesis and progress of endometrial carcinoma (EC). The immune system, a crucial element of TME, functions in various immune cells. In this paper, we have tried to evaluate the prognosis in EC patients by the status of TME. The ESTIMATE algorithm was implemented to computer the number of immune and stromal components in EC tissues from the Cancer Genome Atlas dataset. The CIBERSORT algorithm was employed to assess the proportion of tumor-infiltrating immune cells in EC tissues, which were quantified as Stromal score and Immune score. After the construction of protein–protein interaction network, cell–cell chemokine receptor 2 (CCR2) was identified as a potential predictive element for EC. Further analysis indicated that a higher expression of CCR2 in EC patients was correlated with a better prognosis and a prolonged disease-free survival. According to the transcript level of CCR2, samples were separated into low- and high-expression groups. Gene Set Enrichment Analysis unveiled that metabolism-related pathways were mostly abundant in groups with high-expression, the other one was primarily correlated to immune-related activities. We figured out that some immune cells were positively related to CCR2, suggesting that CCR2 might serve as the immune-dominant status of TME, which was verified by qRT-PCR and HPA analysis in transcriptome and protein level, respectively. Also, CCR2 showed high correlation with immune modulators and chemokine signaling pathway. Thus, the level of CCR2 might have a prognostic value for EC patients, which provides a novel insight for therapeutic strategies of EC.http://dx.doi.org/10.1080/21655979.2021.1947631tumor microenvironment (tme)endometrial carcinoma (ec)cell-cell chemokine receptor2 (ccr2)tcga
spellingShingle Lin Xu
Qin Fang
Youqing Miao
Mengting Xu
Yichun Wang
Lizhou Sun
Xuemei Jia
The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling
Bioengineered
tumor microenvironment (tme)
endometrial carcinoma (ec)
cell-cell chemokine receptor2 (ccr2)
tcga
title The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling
title_full The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling
title_fullStr The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling
title_full_unstemmed The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling
title_short The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling
title_sort role of ccr2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling
topic tumor microenvironment (tme)
endometrial carcinoma (ec)
cell-cell chemokine receptor2 (ccr2)
tcga
url http://dx.doi.org/10.1080/21655979.2021.1947631
work_keys_str_mv AT linxu theroleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT qinfang theroleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT youqingmiao theroleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT mengtingxu theroleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT yichunwang theroleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT lizhousun theroleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT xuemeijia theroleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT linxu roleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT qinfang roleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT youqingmiao roleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT mengtingxu roleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT yichunwang roleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT lizhousun roleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling
AT xuemeijia roleofccr2inprognosisofpatientswithendometrialcancerandtumormicroenvironmentremodeling